Pharmaceuticals, Biotechnology and Life Sciences
Adrenomed AG, the vascular integrity company, has announced that its proprietary sepsis drug candidate Adrecizumab (HAM8101) received a funding commitment of € 7.4 million from the German Federal Ministry of Education and Research (BMBF) as part of the German funding initiatives for the clinical development of COVID-19 drugs and their manufacturing capabilities.
SciRhom GmbH has nominated the anti-iRhom2 antibody it will advance into clinical development. For this antibody, the company has closed an agreement with a top-tier biopharmaceutical manufacturer for the CMC development.
Affimed N.V. (Nasdaq: AFMD) has provided a data update from the ongoing study of the company’s lead innate cell engager (ICE) AFM13 precomplexed with cord blood-derived natural killer (cbNK) cells.
Genmab A/S (Nasdaq: GMAB) announced today an award in the binding arbitration of two matters arising under its license agreement with Janssen Biotech, Inc. (Janssen) relating to daratumumab.
Glatt Ingenieurtechnik GmbH opened a new branch in Cologne. The new unit will showcase the company’s pharmaceutical, biotechnology and active ingredient plant expertise and represents Glatt’s first location in North Rhine-Westphalia.
INEOS Nitriles has announced their intention to invest in a world scale Acetonitrile production facility at their key operating site in Köln, Germany.
Faller Packaging and business partner Rotzinger will exhibit together at Pharmapack in Paris (May 18 and 19, 2022).
The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and Moderna’s Spikevax) in the general population.
iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, has announced the presentation of new preclinical data for its lead program IMT-07 with product candidate OMX-0407, a first-in-class oral SIK3 inhibitor.
Thermo Fisher Scientific has announced new Norwegian-based sales and services team to support customers at every stage of an instrument’s lifecycle, during installation and for any potential maintenance needs, to minimize instrument downtime.